Report cover image

mRNA Cancer Therapeutics Patent Landscape Report and Forecast 2024-2032

Publisher Expert Market Research
Published Aug 28, 2024
Length 200 Pages
SKU # EMAR19135986

Description

mRNA Cancer Therapeutics Patent Landscape Report and Forecast 2024-2032


patents include unique methods for identifying and characterising CTCs without the need for enrichment, enhancing real-time cancer monitoring. Epic Sciences’ contributions to the patent landscape reflect their innovative approach to non-invasive cancer diagnostics and personalised treatment strategies.
  • Ventana Medical Systems Inc. (Roche Group)
Ventana Medical Systems Inc., part of the Roche Group, is renowned for its diagnostic solutions, including those for CTC analysis. Their patents focus on automated staining techniques, imaging systems, and software for detecting and analysing CTCs. Ventana’s integration of CTC technologies into automated platforms highlights their role in advancing clinical diagnostics and improving cancer patient outcomes.
  • Curis Inc.
Curis Inc. is a biotechnology company involved in developing novel cancer therapies, with a growing interest in CTC technologies. Their patents often explore targeted therapies that utilise CTC detection for monitoring treatment efficacy and disease progression. Curis’s innovative approaches in leveraging CTC analysis for therapeutic development contribute significantly to the patent landscape, showcasing their commitment to advancing cancer treatment.

Key Questions Answered in the Circulating Tumor Cells Patent Landscape Report
  • Which companies are the main players in the circulating tumor cells patent landscape?
  • How are patents for circulating tumor cells distributed across different regions?
  • What are the new and emerging trends in circulating tumor cell patents?
  • How has the patent landscape for circulating tumor cells changed over time?
  • What strategic insights are crucial for industry players and investors in the CTC field?
  • What technologies are most commonly patented in the circulating tumor cells industry?
  • How do different patent strategies affect competitive advantage in the CTC industry?
  • What are the broader implications of patent filings in the circulating tumor cells sector?
  • What are the main challenges and opportunities in the CTC patent landscape?
  • What regulatory and legal factors must be considered in the CTC patent landscape?
  • What recent technological innovations have been made in circulating tumor cells?
Reasons to Buy This Report

This patent analysis report provides invaluable insights into circulating tumor cells patent landscape, including technological advancements, key players, and strategic trends. It equips stakeholders with detailed industry intelligence, essential for informed decision-making, competitive analysis, and identifying growth opportunities in a rapidly evolving sector.

Table of Contents

200 Pages
1 Introduction
2 Executive Summary
3 Global mRNA Vaccine and Therapeutic Market Overview
3.1 Global mRNA Vaccine and Therapeutic Market Historical Value (2017-2023)
3.2 Global mRNA Vaccine and Therapeutic Market Forecast Value (2024-2032)
4 Global mRNA Vaccine and Therapeutic Market Segmentation
4.1 Global mRNA Vaccine and Therapeutic Market Share by Type
4.1.1 Market Overview
4.1.2 Self-Amplifying mRNA Vaccines
4.1.3 Non-Amplifying mRNA Vaccines
4.2 Global mRNA Vaccine and Therapeutic Market Share by Route of Administration
4.2.1 Market Overview
4.2.2 Intravenous
4.2.3 Intramuscular
4.2.4 Intranasal
4.2.5 Others
4.3 Global mRNA Vaccine and Therapeutic Market Share by Therapeutic Area
4.3.1 Market Overview
4.3.2 Infectious Diseases
4.3.3 Oncological Disorders
4.3.4 Other Disorders
5 Global Market Dynamics
5.1 Market Drivers and Constraints
5.2 Porter’s Five Forces Analysis
5.3 PESTEL Analysis
5.4 Industry Events, Initiatives, and Trends
5.5 Value Chain Analysis
6 Global mRNA Cancer Therapeutics Patent Landscape Analysis
6.1 Patent Distribution by Publication Year
6.2 Patent Distribution by Application Year
6.3 Patent Distribution by Priority Year
6.4 Analysis by Type of Patent
6.4.1 Granted Patents
6.4.2 Patent Application
6.4.3 Amended Application
6.4.4 Search Report
6.5 Analysis by Legal Status
6.5.1 Active
6.5.2 Pending
6.5.3 Expired/Discontinued
6.6 Analysis by Patent Jurisdiction
6.7 Analysis by Patent Age
6.8 Analysis by Cooperative Patent Classification (CPC) Codes
6.9 Average Time to Publish a Patent
6.9.1 By Entities
6.9.2 By Jurisdiction
6.9.3 By Technology
6.10 Analysis by Type of Entity (Academic and Non-Academic)
6.11 Analysis by Top Applicants
6.12 Analysis by Top Inventors
7 Global mRNA Cancer Therapeutics Patent Analysis by Technology
7.1 Total Patents by Top Technologies
7.2 Time Evolution of Patents by Technology
7.3 Emerging Technologies
7.4 Patent Segmentation, By Carrier
7.4.1 Time Evolution by Number of Patents
7.4.2 Time Evolution by Number of Patent Families
7.4.3 Analysis by Type of Entity (Academic vs Non-Academic)
7.4.4 Analysis by Top Applicants
7.4.5 Analysis by Top Inventors
7.5 Patent Segmentation, By Route of Administration
7.6 Patent Segmentation, By Delivery Route
*Complete technology list will be provided in the report.
8 EMR Patent Valuation Analysis
8.1 Assessment Methodology
8.2 High Value Patents
8.3 Medium Value Patents
8.4 Low Value Patents
9 Global mRNA Cancer Therapeutics – Top 10 Players Patent Analysis
9.1 Top 10 Entities by Number of Patents
9.2 Analysis by Publication Year
9.3 Analysis by Application Year
9.4 Analysis by Priority Year
9.5 Analysis by Type of Patent
9.6 Analysis by Jurisdiction
9.7 Analysis by Cooperative Patent Classification (CPC) Codes
9.8 Analysis by Source of Innovation
9.9 Analysis by Forward and Backward Citations
9.10 Analysis by Legal Status
9.11 Analysis by Patent Age
9.12 Analysis by Key Inventors
9.13 Entity Dynamics
9.13.1 Analysis by Type of Player (Academic vs Non-Academic)
9.13.2 Analysis by Collaboration
9.13.3 Analysis by Technology
9.13.4 Newcomers
9.13.4.1 Start-up Companies
9.13.4.2 Established Companies
10 Patent Profile of Key Players
10.1 Pfizer, Inc.
10.1.1 Product Portfolio
10.1.2 Patent Portfolio by Patent Families
10.1.3 Time Evolution of Patents
10.1.4 Geographical Patent Coverage
10.1.5 Patent Analysis by Technology
10.1.6 Patent News and Developments
10.1.7 Financial Analysis
10.1.8 SWOT Analysis
10.2 Modernatx Inc
10.3 Novartis AG
10.4 Genentech Inc.
10.5 Immatics Biotechnologies GmbH
11 Future Trends
12 Global mRNA Vaccine and Therapeutic Market Landscape (Additional Insight)*
12.1 Global mRNA Vaccine and Therapeutic: Developers Landscape
12.1.1 Analysis by Year of Establishment
12.1.2 Analysis by Company Size
12.1.3 Analysis by Region
12.2 Global mRNA Vaccine and Therapeutic: Product Landscape
12.2.1 Analysis by Product Type
12.2.2 Analysis by Technology
12.2.3 Analysis by Application
*Additional insights are not provided in the standard report.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us